Posts

Does Russia stand to benefit from climate change?

“There’s a narrative out there about climate change that says there are winners ...

Climate change could push bowhead whales to cross paths...

This press release is available online at: https://news.agu.org/press-release/cl...

Vlasov and Bashir groups develop nanoscale device for b...

Longstanding challenges in biomedical research such as monitoring brain chemistr...

How Americans really feel about the teaching of controv...

While Americans overwhelmingly agree on the fundamental value of public educatio...

Human-AI coworking

Though artificial intelligence decreases human error in experimentation, human e...

Cancer leaders pens “letter to the world” calling for u...

In their ‘letter to the world’ they say that cancer is a ‘defining health issue ...

Researchers develop molecules for a new class of antibi...

(Santa Barbara, Calif.) — About a decade ago, researchers in UC Santa Barbara ch...

Seaports are hotspots of contagious cancer in mussels

Seaports act as hubs for the global spread of MtrBTN2,1 a rare contagious cancer...

Intravascular imaging significantly improves survival, ...

Using intravascular imaging to guide stent implantation during percutaneous coro...

Innovative technology for the comprehensive analysis of...

1. Background Credit: By Kohdai Yamada, Sawasaki Tatsuya(Ehime University) 1. ...

Modeling tree masting

The effects of a phenomenon called tree masting on ecosystems and food webs can ...

New Player Latigo in Pain Biotech Challenges Vertex

A new contender has emerged in the domain of pain-focused biotechnology, marking...

Denali-Sanofi’s ALS Candidate Falls Short in Mid-Stage ...

Denali and Sanofi have been working together since 2018, when they reached an ag...

Setbacks Mount for Gilead’s Magrolimab Trials as FDA En...

In a chain of unfolding events reminiscent of the tumbling of dominos, Gilead Sc...

RioDerm-001 by Rion for Diabetic Foot Ulcers: Likelihoo...

RioDerm-001 is under clinical development by Rion and currently in Phase II for ...

SY-001 by CellOrigin Technology (Hangzhou) for Solid Tu...

SY-001 is under clinical development by CellOrigin Technology (Hangzhou) and cur...